Correlation Between BankInvest Emerging and Genmab AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BankInvest Emerging and Genmab AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BankInvest Emerging and Genmab AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BankInvest Emerging and Genmab AS, you can compare the effects of market volatilities on BankInvest Emerging and Genmab AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BankInvest Emerging with a short position of Genmab AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of BankInvest Emerging and Genmab AS.

Diversification Opportunities for BankInvest Emerging and Genmab AS

0.81
  Correlation Coefficient

Very poor diversification

The 3 months correlation between BankInvest and Genmab is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding BankInvest Emerging and Genmab AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genmab AS and BankInvest Emerging is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BankInvest Emerging are associated (or correlated) with Genmab AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genmab AS has no effect on the direction of BankInvest Emerging i.e., BankInvest Emerging and Genmab AS go up and down completely randomly.

Pair Corralation between BankInvest Emerging and Genmab AS

Assuming the 90 days trading horizon BankInvest Emerging is expected to generate 0.19 times more return on investment than Genmab AS. However, BankInvest Emerging is 5.26 times less risky than Genmab AS. It trades about -0.26 of its potential returns per unit of risk. Genmab AS is currently generating about -0.3 per unit of risk. If you would invest  16,735  in BankInvest Emerging on January 26, 2024 and sell it today you would lose (200.00) from holding BankInvest Emerging or give up 1.2% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

BankInvest Emerging  vs.  Genmab AS

 Performance 
       Timeline  
BankInvest Emerging 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in BankInvest Emerging are ranked lower than 6 (%) of all funds and portfolios of funds over the last 90 days. Despite somewhat strong primary indicators, BankInvest Emerging is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Genmab AS 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Genmab AS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Genmab AS is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

BankInvest Emerging and Genmab AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BankInvest Emerging and Genmab AS

The main advantage of trading using opposite BankInvest Emerging and Genmab AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BankInvest Emerging position performs unexpectedly, Genmab AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genmab AS will offset losses from the drop in Genmab AS's long position.
The idea behind BankInvest Emerging and Genmab AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios